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Abstract
Grain legume consumption has been linked in meta-analysis studies to decreased risk
of metabolic syndrome, obesity, and cardiovascular diseases; however, the evidence for
a chemo-protective effect of grain legume consumption against colorectal tumorigenesis
has been considered inconclusive. We conducted a meta-analysis of human and animal
studies to evaluate the effect of grain legume consumption on colorectal cancer (CRC)
and its precursors. Twelve case-control studies (42,473 controls and 12,408 cases) and
11 prospective cohorts (1,533,527 participants including 12,274 cases) were included in
the meta-analysis; the pooled risk ratio (95% confidence interval) for the highest versus
the lowest legume intake group based on a random effects model was 0.72 (0.60–0.89)
for incident adenoma, 0.91 (0.84–0.99) for prevalent adenoma, and 0.82 (0.74–0.91) for
CRC. Fourteen animal studies (355 animals on grain legume diets and 253 animals on
control diets) were included in the meta-analysis and showed in all but one study a
chemo-preventive  effect  against  colorectal  tumorigenesis.  Grain  legumes  contain
various compounds (e.g., resistant starch, soluble fiber, insoluble fiber, phytosterols,
saponins, phytates, flavonoids, proanthocyanidins, and phenolic acids) that have been
shown to inhibit colorectal tumorigenesis in animal studies at concentrations that are
relevant for human diets. Grain legume consumption alters several molecular pathways
(e.g.,  p53,  mTOR,  NF-kB,  Akt,  and  AMPK)  that  are  critical  for  tumor  induction,
promotion, and progression. Based on our meta-analysis, daily grain legume consump-
tion confers chemo-preventive effects against CRC.
Keywords: grain legumes, colorectal cancer, meta-analyses, bioactive compounds,
molecular mechanisms
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Grain  legumes  (i.e.,  pulses)  are  defined  as  plants  belonging  botanically  to  the  family
Leguminosae, which are harvested as dry seeds for food consumption [1–3]. Grain legumes
are behind cereal grains the most common food crop worldwide; the primarily grown grain
legumes are in the order as follows: dry beans (e.g., pinto, navy, red kidney, lima, butter,
white,  and black beans;  Phaseolus  and Vigna  ssp.),  chick peas (i.e.,  garbanzo beans;  Cicer
arietinum), dry peas (e.g., garden peas; Pisum sativum), dry cow peas (Vigna unguiculata), lentils
(Lens culinaris), and dry broad beans (e.g., horse beans; Vicia faba) [3–5]. Beans are oval or
kidney shaped, peas are round, and lentils are flat. Grain legumes have served as staple foods
in many cultures around the globe, as they can be grown relatively inexpensively in various
climate zones and have a health-promoting nutrient profile, that is, they are a good dietary
source of protein, rich in fiber and folate, and very low in saturated fatty acids, cholesterol,
and sodium [6–8].
Grain legume consumption dramatically decreased in westernizing countries [9] and is in
the U.S., similar to other Western countries [10, 11], on average low (12.9 g/d) and infrequent
(only 8 and 14% consumed grain legumes daily or every other day) [6, 12]. Given the health-
promoting properties and nutrient profile of grain legumes and the growing interest in
ethnic, gluten-free, and vegetarian cuisine in Western countries, increasing grain legume
consumption represents an important public health opportunity for chronic disease
prevention.
A research focus is the use of legumes for cancer prevention, specifically colorectal cancer
(CRC) [4]. Globally, CRC is the third most common cancer in men and the second most
common in women [13]. Two recent A meta-analysis study reported a protective effect of
legume consumption for colorectal adenomas (CRAs) in case-control and cohort studies
(combined odds ratio (OR) = 0.83; 95% confidence interval (CI): 0.75–0.93) and CRC in cohort
studies (OR = 0.91; 95% CI: 0.84–0.98) [14, 15]. Both meta-analysis studies, however, included
studies in which participants consumed legumes primarily as soy products (i.e., studies
conducted in China, Japan, Malaysia, and South Korea), as opposed to grain legumes (i.e.,
studies conducted in Africa, North and South America, and Europe). Moreover, the meta-
analysis of CRC showed a protective effect for soybeans (OR = 0.85; 95% CI: 0.73–0.99) but
not for other beans (OR = 1.00; 95% CI: 0.89–1.13) [15]. A third meta-analysis study published
in 2010 reported no statistically significant association between legume fiber consumption
and CRC in four prospective U.S. and European studies combined (OR = 0.89; 95% CI: 0.78–
1.02) [16].
The objective of this chapter is to evaluate the evidence of a chemo-preventive role of grain
legume consumption in colorectal tumorigenesis in human (ecological, case-control, and
cohort studies) and animal studies by conducting a literature review and meta-analyses. The
goal is to suggest areas of future research and provide up-to-date scientific evidence for dietary
recommendation of legume consumption.
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2. Colorectal cancer: incidence, mortality, and risk factors
Worldwide, annually 1.361 million new CRC cases and 0.694 million deaths due to CRC accrue,
according to GLOBOCAN in 2012 [13, 17]. In the U.S., the lifetime risk of being diagnosed with
CRC is 5% and the treatment costs were estimated to be over $14 billion [18, 19], highlighting
CRC prevention as a public health priority. CRC development is a multistep process over many
years, often decades, involving usually random genetic mutations in colorectal epithelial cells
causing the activation of tumor-promoting genes and the loss of tumor suppressor gene
function [20, 21]. Starting often as aberrant crypt foci (ACF), most CRC arise from benign,
adenomatous polyps (i.e., adenomas) that grow from glandular cells of the colorectal epithelial
lining into advanced adenomas and then adenocarcinomas [22–24]. Over 50% of the Western
population will develop colorectal adenomas (CRAs) by the age of 70 [23]. Less than 10% of
adenomas, however, progress to become invasive and spread to adjacent blood or lymph
vessels [25]. Success of CRC treatment depends on early detection. If CRC has not spread
beyond the colorectal wall (i.e., localized stage), 5-year survival rates are 90.3%; however,
survival rates decline when CRC has spread to lymph nodes and/or nearby tissue (i.e., regional
disease; a 5-year survival of 70.4%) and are low when CRC has spread to other organs (i.e.,
distant disease; a 5-year survival of 12.5%) [26]. Currently, only 40% of CRC patients are
diagnosed with localized stage, highlighting that importance of early detection and treatment
of CRC and its precursors [27].
Genetics is an important CRC risk factor. About 20% of CRC patients have a family history of
CRC (10–15% lifetime risk for patients with one first-degree relative; 20% lifetime risk for
patients with at least two first-degree relatives or one first-degree relative diagnosed with CRC
before age 45) and 2–4% have a well-defined genetic syndrome (i.e., Lynch syndrome and
familial polyposis; 80–90% lifetime risk) [19]. Chronic inflammation, specifically inflammatory
bowel disease (IBD), is another important CRC risk factor with a 10–20% lifetime risk, which
is increased among patients with a longer IBD history [19, 28]. Other important medical CRC
risk factors are obesity, insulin resistance, and diabetes mellitus; CRC risk increases linearly
with duration and severity of those morbidities [19, 29–33]. Modifiable CRC risk factors include
smoking, heavy alcohol consumption, and sedentary behavior, each with a 6% lifetime risk
[19], whereas medications such as aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)
and hormone-replacement therapy in postmenopausal women can decrease CRC risk [19].
Food and nutrition play an important part in the etiology and prevention of CRC and may
account for 70–90% of all cases [34–36]. A panel of experts, primarily epidemiologists organized
by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research
(AICR), evaluated the scientific evidence on food, nutrition, and physical activity on cancer
risk [34]. Human studies were ordered according to the quality of the study design as follows:
(1) ecological studies (lowest quality; most susceptible to confounders; i.e., factors that are
associated with both disease status and the evaluated food); (2) case-control studies (very
susceptible to recall bias; i.e., selective reporting of the diet after disease diagnosis); (3)
Prospective cohort studies; and (4) clinical trials (gold standard and least susceptible to bias).
In the case of substantial amount of evidence available, the panel focused on studies using
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high-quality designs. Evidence from animal and cell culture studies was taken into account to
demonstrate plausible mechanism for diet and cancer association. Based on the evidence, an
individual food, food group, or individual nutrient was classified for each cancer site as
“convincing”, “probable”, “limited-suggestive”, or “limited-no conclusion” decreases the risk
or increases the risk [34].
In 2007, the panel classified red and processed meat consumption as convincingly increases
CRC risk, whereas calcium and foods containing fiber were classified as probably decreases
CRC risk, and selenium and foods containing folate were classified as limited-suggestive
evidence for decreasing CRC risk [34]. No conclusion was made for legumes and CRC risk
because of the limited data available in 2007 [34]. As in the last 8 years more data have been
collected, we reevaluate in this chapter the evidence on the relation between grain legume
consumption and CRC risk. We hypothesized a protective effect of grain legume consumption
on CRC risk because grain legumes are an excellent dietary source of fiber (5.7–9.0 g/100 g of
cooked legumes) and folate (83–174 μg/100 g of cooked legumes) [7], both of which were
classified as decreasing CRC risk in 2007 [34].
3. Grain legumes and colorectal neoplasia in human studies
Ecological studies examine the association between diet and disease on the population level;
five studies evaluated the relation between legume intake and risk of CRC incidence or
mortality on the population level and observed inconsistent relations [9, 37–40]. Correa
reported that countries with higher bean consumption in 1964–1966 had lower colon cancer
mortality rates 7–9 years later (r = −0.68) [40]. Similarly, Bejar et al. stated that the decrease in
legume consumption between 1960 and 1990 coincided with an increase in CRC incidence and
mortality rates 10 years later in Spain [37, 39]. In follow-up studies, Bejar et al. extended the
analysis to 15 European and 13 non-European countries [9, 38]. Whereas the strong inverse
relation between legume intake and CRC incidence rates held true for some countries (i.e.,
Norway, Spain, Germany, and France), other countries (i.e., Australia, Italy, and Colombia) had
positive relations, as a result of a slight increase in legume consumption between 1965 and
2005. Thus, changes in legume consumption alone cannot explain the temporal changes in CRC
incidence rates; rather, changes toward a Western diet were associated with an increased CRC
risk (depending on country of origin, adoption of a westernized diet either increased or
decreased grain legume consumption). In support, Monroe et al. reported in a migrant study
that an increase of CRC incidence rates (men: 85%; women: 95%) coincided with a 46% decrease
in dry bean or pea consumption (57.0–26.6 g/d) from first- to second-generation Mexico-born
U.S. Americans in the Multiethnic Cohort Study [41], and Haentzel et al. showed a detrimental
effect of grain legume consumption on CRC incidence in Japan-born Hawaiian [42].
In case-control studies, participants with (cases) or without (controls) a disease recall their diet.
Besides recalling a diet from past years, participants try to make sense of their disease outcome
based on their lifestyle choices. Thus, foods and food groups that have been known to be
associated with disease outcomes by the public are often erroneously associated with the
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disease outcome (i.e., selective reporting bias). Nineteen peer-reviewed publications (46,769
controls and 14,567 cases; two studies had each two publications [43, 44] and [45, 46]) evaluated
in 17 case-control studies the relation between legume consumption and colorectal neoplasia;
six studies reported prevalent adenomas as endpoint [47–52] and 11 studies reported carcino-
mas as endpoint [42–46, 53–60] (Table 1). Most case-control studies were from the U.S. (n = 8),
five were from Europe, two were from South America, and one each from Australia and Jordan.
Risk estimates specific to the intake of legumes (including soybeans and their products), grain
legumes, and grain legume fiber were reported in six, 11, and two case-control studies,
respectively. Gender-specific risk estimates were reported in five case-control studies, and
cancer-site–specific risk estimates were reported for colon and rectum in seven and four case-
control studies, respectively. Half of the studies showed a protective legume effect on CRA
(Table 1), one of which was statistically significant [50]. A distinct clustering was observed for
CRC. Seven of 11 case-control studies had significant risk estimates of 0.5 or lower [45, 46, 50,
53, 55, 56, 59, 60]; three of the six low-risk estimates were from women and, for the remaining
three, no gender-specific risk estimates were reported. In contrast, the risk estimates of the
other studies were around 0.9 (Table 1).
Reference, region
(country)
Study
period
Study design, no.
controls/cases
Sex, age Diet assessment Grain legume, quantity for comparison,
risk estimates (95% CI)
Matching/adjusting for confounders
Prevalent colorectal adenoma
Sandler et al., 1993 [47]
North Carolina (U.S.)
1988–
1990
Colonoscopy
Cases: 236
Controls: 409
Both,
≥30 years, no
CRC, IBD
history
Phone interview: FFQ with
>100 food items for
previous yr 
Grain legume fiber
Men:
≥3.14 vs. <0.97 g/d OR = 0.99 (0.43–2.29)
Women:
≥2.17 vs. <0.61 g/d OR = 1.26 (0.63–2.51)
No matching specified
Adjusted for age, alcohol intake, BMI,
and total energy intake
Witte et al., 1996 [48]
California (U.S.)
1991–
1993
Sigmoidoscopy
Cases: 488
Controls: 488
Both
50–74 years; no
CRA, IBD
history
Personal interview: FFQ
with 126 food items for
previous yr
Legumes (beans, lentils, peas, lima beans,
tofu, soybeans, peanut butter)
Mean 8.5 vs. 0.5 servings/wk OR: 0.85
(0.56–1.28)
Matched by age, sex, day of
sigmoidoscopy, Kaiser center
Adjusted by race, BMI, physical
activity, smoking, and intake of total
energy and saturated fat
Smith-Warner
et al., 2002 [49]
Minnesota Cancer
Prevention Research
Unit Study (U.S.)
1991–
1994
Colonoscopy
and population
Cases: 564
Controls: 682
colonoscopy,
535 population
Both, 30–74
years, no CRA,
IBD history
Self-administered FFQ
precolonoscopy with >153
food items for previous yr
Legumes (alfalfa sprouts, beans, peas)
Men: Mean 5.0 vs. 1.0 servings/wk
Colonoscopy: OR = 0.96 (0.62–1.49)
Population: OR = 1.15 (0.77–1.72)
Women: Mean 5.5 vs. 1.1 servings/wk
Colonoscopy: OR = 1.08 (0.68–1.74)
Population: OR = 0.96 (0.58–1.59)
Matched by age, sex, and residence
Adjusted for age, total energy and fat
intake, BMI, smoking, alcohol,
NSAID use, multivitamin use, and
hormone replacement therapy
Agurs-Collins
et al., 2006 [50]
African-American
(U.S.)
2001–
2003
Colonoscopy
Cases: 53
Controls: 133
Both,
29–81 years
FFQ with 39 food items
(Rate Your Diet Quiz)
Grain legumes (dry beans, split peas,
lentils)
≥3× vs. ≤1×/wk OR = 0.19 (0.04–0.91)
No matching specified
Adjusted for age, smoking, alcohol,
sex, weight, aspirin use, alcohol,
family CRC history, and exercise
Millen et al., 2007 [51]
Prostate, Lung,
Colorectal, and Ovarian
Cancer Screening Trial
(PLCO)
1993–
2001
Sigmoidoscopy
Cases: 3057
Controls: 29,413
Both, 55–
74 years; no
CRA, IBD
history
Self-administered FFQ pre-,
on, or post-sigmoidoscopy
with 137 food items for
previous yr
Legumes
(beans, peas,
tofu, and soybeans)
Median 0.4 vs. 0.05 energy-adjusted
servings/wk OR = 0.92 (0.81–1.03)
Sex and age adjusted: OR = 0.85 (0.75–0.96)
Matching not specified
Adjusted for age, sex, race,
education, family CRC history,
smoking, alcohol use, aspirin use,
replacement hormone use, physical
activity, BMI
Wu et al., 2009
[52] Tennessee
Colorectal
Polyp Study (U.S.)
2003–
2005
Colonoscopy
Cases: 764
Controls: 1517
Both, 40–
75 years, no
CRA, IBD
history
FFQ with >108 food items
for previous yr
Grain legumes (green beans and peas, dry
and canned beans)
Tertile T3 vs. T2 Quantity N/A
OR = 0.95 (0.74–1.24)
No matching specified
Adjusted for age, sex, race, study
location, BMI, smoking, alcohol
consumption, NSAID use, physical
activity, education level, family
income, family CRC history, and
intake or total energy and red meat
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Reference, region
(country)
Study
period
Study design, no.
controls/cases
Sex, age Diet assessment Grain legume, quantity for comparison,
risk estimates (95% CI)
Matching/adjusting for confounders
Colon Cancer
Iscovich et al., 1992 [56]
La Plata (Argentina)
1985–
1987
Population
Cases: 110 Controls:
220
Both, 35–
80 years
Personal
interview FFQ with 140
food items for previous 5
yrs
Grain legumes (beans, lentils, peas, and
chick peas)
Quartile 4 vs. 1 OR = 0.52 (0.24–1.12)
Quartile 3 vs. 1 OR = 0.32 (0.14–0.73)
Quantity N/A
Matched by age and gender
Adjustment not specified
Steinmetz et al., 1993
[60]
Adelaide (Australia)
1979–
1980
Population
Cases: 220 Controls:
438
Both,
30–74 years
Self-administered FFQ with
141 food items a yr ago
Legumes (green, dry and broad beans,
lentils, dry and chick peas, and soybeans)
Men: >1 vs. 0 servings/wk OR = 0.74 (0.38–
1.45); Women: >0.6 vs. 0 servings/wk OR =
0.43 (0.20–0.93)
Matched by age and gender
Adjusted for protein intake,
occupation, Quetelet’s index, alcohol
consumption, and age at first live
birth (only women)
Kampman et al., 1995
[57]
(Netherlands)
1989–
1993
Population
Cases: 232 Controls:
259
Both,
≤75 years, no
history of CR
tumors
Personal
interview: FFQ with 289
food items for previous yr 
Legumes
Quartile 4 vs. 1 (infrequent legume
consumption) OR = 1.08 (0.67–1.76)
Matched by age, gender, and degree
of urbanization
Adjustment not specified
Colorectal Cancer
Haenszel et al., 1973
[42]
Hawaiian born in Japan
(U.S.)
1966–
1970
Hospital
Cases: 179 Controls:
357
Both
Age N/A
Personal
interview: four legumes,
soybeans excluded
Grain legumes (green and red beans, peas,
and Chinese peas)
>21× vs. <8×/mo legumes RR = 3.5 95% CI
N/A
Matched by sex and birth place
Adjustment not specified
La Vecchia et al., 1988
[58]
Milan
(Northern Italy)
1985–
1987
Hospital
Cases: 339
colon, 236 rectal
Controls: 778
Both,
<75 years
Personal
interview: 29 food items
prior to disease diagnosis
Grain legumes
Tertile 3 vs. 1 Quantity N/A
Colon: RR = 1.04; Rectum: RR = 0.94
95% CI N/A
Matching not specified
Adjusted for social class, age, sex,
and area of residence
Benito et al., 1991 [53]
Majorca (Spain)
1984–
1988
Population and
Hospital
Cases: 286 Controls:
203 hospital
286 population
Both,
<80 years
Personal
interview: FFQ with 99
food items for previous yr
Grain legume fiber
Quartile 4 vs. 1 Quantity N/A
RR = 0.40 95% CI N/A
Matched by age and gender
Adjusted for age, sex, body weight,
and total energy intake
Bidoli et al., 1992 [54]
Pordenone (North
Eastern Italy)
1986–
1990
Hospital
Cases:
123 colon, 125 rectal
Controls: 699
Both
Age not
specified
Personal
interview: FFQ (number of
food items N/A before
disease) onset
Grain legumes
Tertile 3 vs. 1 Quantity N/A
Colon: RR = 1.2 Rectum: RR = 0.8
95% CI N/A
Matched by hospital
Adjusted for age, gender, and social
status
Le Marchand et al.,
1997 [59]
Hawaii Multiethnic
(U.S.)
1987–
1991
Population
Cases: 1192
Controls: 1192
Both
<85 years, no
history of
colorectal
tumors
Personal
interview: FFQ with 282
food items 3 yrs before
disease onset
Legumes (including soy products)
Men: >46 vs. <11 g/d OR = 0.8 (0.5–1.2)
Women: >44 vs. <9 g/d OR = 0.5 (0.3–0.9)
Matched by age, sex, and race
Adjusted for age, family CRC history,
alcohol consumption, smoking,
physical activity, Quetelet index, and
intake of total calories, eggs, and
calcium
Franceschi et al., 1998
[55]
(Italy)
1991–
1996
Hospital
Cases:
1225 colon 728 rectal
Controls: 5155
Both
Age not
specified
Personal
interview: FFQ with 98
food items 2 yrs before
disease diagnosis
Grain legumes (beans and peas)
>3 vs. <0.5 servings/wk
Colon: OR = 0.5 (0.4–0.7)
Rectum: OR = 0.7 (0.5–0.9)
Matching not specified
Adjusted for age, sex, center, year of
interview, education, physical
activity, alcohol consumption, and
total energy intake
Deneo-Pellegrini et al.,
2002 [46]
Montevideo (Uruguay)
1996–
2002
Hospital
Cases: 484 Controls:
1452
Both
30–89 years
Personal
interview: FFQ with 64
food items a yr before
disease diagnosis
Grain legumes
(kidney beans and lentils)
Quartile 4 vs. 1 Quantity N/A
Overall: OR = 0.7 (0.5–0.9)
Men: OR = 0.8 (0.5–1.2)
Women: OR = 0.5 (0.3–0.9)
Colon: OR = 0.9 (0.9–1.1)
Rectum: OR = 0.8 (0.7–0.9) 
Matched on age, sex, residence, and
urban/rural status
Adjusted for age, sex, rural/urban
status, education, first-degree family
CRC history, BMI, and intake of total
energy and red meat
Aune et al., 2009 [45]
Montevideo (Uruguay)
1996–
2004
Hospital
Cases: 3539
Controls: 2032
Both
26–89 years
Personal
interview: FFQ with 64
food items a yr before
disease diagnosis
Grain legumes (kidney beans and lentils)
Legume: Median 14.38 vs. 1.35 g/d OR =
0.43 (0.32–0.59)
Beans: Median 9.44 vs. 0 g/d OR = 0.44
(0.31–0.61)
Lentils: Median 11.68 vs. 0 g/d OR = 0.53
(0.38–0.75)
Matching not specified
Adjusted for age, sex, residence, BMI,
education, income, interviewer,
smoking status and history, alcohol
consumption, mate drinking status,
and intake of total energy, dairy
products, fatty foods (eggs, cake,
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Reference, region
(country)
Study
period
Study design, no.
controls/cases
Sex, age Diet assessment Grain legume, quantity for comparison,
risk estimates (95% CI)
Matching/adjusting for confounders
custard, butter), fruits and
vegetables, and total meat
Abu Mweis et al., 2015
[43]
(Jordan)
2010–
2012
Hospital
Cases: 167
Controls: 240
Both
>18 years
Self-administered
FFQ with 109 food and
beverage items (DHQ 1) a
yr before disease diagnosis
Lentils
>1× vs. <1×/wk OR = 1.49 (0.80–2.79)
Matched by age, sex, occupation, and
marital status
Adjusted for age, sex, family CRC
history, physical activity, smoking,
education level, marital status, work,
income, and total energy intake
Tayyem et al., 2015 [44]
(Jordan)
2010–
2012
Hospital
Cases: 220
Controls: 281
Both
>18 years
Self-administered FFQ with
109 food and beverage
items (DHQ 1) a yr before
disease diagnosis
Lentils
1×/wk vs. <1×/mo OR = 1.3 (0.72–2.4)
White beans
1×/wk vs. <1×/mo OR = 0.86 (0.37–2.1)
Green beans
1×/wk vs. <1×/mo OR = 1.0 (0.57–2.2)
Peas
1×/wk vs. <1×/mo OR = 1.0 (0.44–2.0)
Matched by age, sex, occupation, and
marital status
Adjusted for age, sex, family CRC
history, physical activity, smoking,
education level, marital status, work,
income, and total energy intake
*Statistically significant association of legume consumption and colorectal neoplasia.
CRA: colorectal adenoma; CRC: colorectal cancer; FFQ: food frequency questionnaire; IBD: inflammatory bowel
disease; mo: month; N/A: not available; OR: odds ratio; RR: relative risk; wk: week; 95% CI: 95% confidence interval.
1 serving of legume equals 0.5 cup of cooked legumes (~90 g) [7].
Table 1. Description of retrospective case-control studies of grain legume consumption and colorectal neoplasia.
Figure 1. Forest plot of legume consumption (highest vs. lowest category) and colorectal neoplasia risk in retrospective
studies stratified by type of neoplastic lesion and gender (only for cancer studies). The dot in each study indicates the
estimated risk ratio, vertical bars represent 95% CI, and the size of gray square box reflects the study’s weight in the
random effects meta-analysis. The straight line indicates no association and the dashed line indicates the summary risk
estimate across all studies. The open diamond on the bottom indicates the pooled risk estimate and the right vertices of
the diamond reflect the 95% CI. CC: colon cancer; RC: rectal cancer; CRC: colorectal cancer; CRA: colorectal adenoma;
GrLeg: grain legume; GrLegF: grain legume fiber; Leg: legume; LegF: legume fiber.
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Meta-analysis using a random effects model of natural log odds ratios (OR) in STATA was
possible for 12 case-control studies [46–52, 55–57, 59, 60] that included 12,408 cases and 42,473
controls. We had to exclude the four oldest case-control studies [42, 53, 54, 58] because the 95%
CIs were not reported and two case-control studies [43, 44] provided only estimates of
individual grain legumes. We checked for heterogeneity of estimates, influential risk estimates,
and publication bias using funnel plots and Egger’s method. When comparing the highest
versus the lowest legume intake group, we observed a protective effect of legume consumption
on CRA (relative risk (RR) = 0.93; 95% CI: 0.84–1.03; P = 0.15) and CRC (RR = 0.65; 95% CI: 0.54–
0.77; P <0.001). There was moderate heterogeneity (30.2%) among studies for CRC risk (P =
0.17), but <0.01% for CRA risk. The range of risk estimates was 0.56–0.65 for CRC after removing
one study at a time. No significant publication bias was observed (P = 0.11). The heterogeneity
among CRC risk estimates could be explained by gender-specific differential dietary recalls
(Figure 1); the protective effect of legume consumption on CRA was in men, RR = 0.79 (95%
CI: 0.84–1.03; P = 0.10; <0.01 heterogeneity), in women, RR = 0.49 (95% CI: 0.34–0.69; P <0.0001;
<0.01% heterogeneity), and intermediate RR = 0.67 (95% CI: 0.48–0.93; P = 0.02; 63.1% hetero-
geneity) in studies that did not provide gender-specific estimates.
In prospective cohort studies, dietary information of cohorts or groups of healthy individuals
at the time of study recruitment is linked to subsequent disease outcomes. We evaluated the
relation between legume consumption and colorectal neoplasia in 15 peer-reviewed publica-
tions from 11 prospective cohorts (1,621,519 participants with 13,546 cases), 11 reported cancer
as endpoint [61–71] and the remaining four studies reported incident and/or prevalent
adenomas as endpoint [72–75] (Table 2). All, except for two European cohorts, were U.S.
cohorts. Risk estimates were reported for men in six and for women in eight prospective
cohorts. Risk estimates specific to colon and rectum were reported in two and one cohorts,
respectively. Risk estimates specific to the intake of legumes, legume fiber, grain legumes, and
grain legume fiber were reported in three, three, three, and two cohorts, respectively. Two
cohorts (Adventist Health Study and Polyp Prevention Trial) showed significant protective
effects of grain legume consumption [69, 72, 75]. Four cohorts (Breast Cancer Detection
Demonstration Project, Women’s Health Study, Multiethnic Cohort Study, and NIH-AARP
Study) showed a protective effect on CRC risk, the effect was statistically significant in some
statistical models in the latter three cohorts [63, 64, 66–68]. Two cohorts (Nurses’ Health Study
and Health Professionals’ Follow-up Study) showed a protective effect of legume consumption
for CRA only [65, 73, 74]. Only three of the 11 cohorts (Iowa Women’s Health Study and two
European cohorts) showed no effects of legume consumption on CRC risk [61, 62, 70, 71].
Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
Incident colorectal adenoma
Lanza et al., 2006
[72]
1991–1994;
4-yr trial;
1905,
629
Both,
>35 years
Four annual
self-
Grain legumes (dry
beans and lentils)
Adjusted for age,
NSAIDs, sex,
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Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
U.S., Polyp
Prevention Trial
(PPT)
incident
CRA <3
yrs old
No CRC,
IBD
history
administered
FFQ with 27
food items and
one grain
legume
question for
previous yr
Mean: 45.1 vs. 3.1
g/d
Any: OR = 0.78
(0.58–1.04)
Men: OR = 0.69
(0.48–0.99)
Advanced: OR =
0.30 (0.15–0.60)
intervention group,
and sex by
intervention group
Michels et al.,
2006 [73]
U.S., Nurses’
Health Study
(NHS)
Diet: 1980–
1994,
incident
CRA >2
yrs old
9735,
633
No CRA,
IBD
history
Women
30–55 years
in 1976
Self-
administered
FFQ with 61
food items for
previous yr
Legumes (beans,
lentils, peas, lima
beans, tofu,
soybeans)
≥5 vs. ≤ 1
serving/wk
New Incidence
only: OR = 0.67
(0.51–0.90) Trend:
OR = 0.92 (0.87–
0.98)
Adjusted for age,
family CRC history,
height, BMI, regular
vigorous exercise,
regular aspirin use,
pack-years of
smoking, current
multivitamin
supplement use,
alcohol consumption,
menopausal status,
postmenopausal
hormone use, and
intake of total energy,
red meat, and
calcium
Tantamango
et al., 2011 [75]
U.S., Adventist
Health Study
(AHS)
Diet: 1976–
1977,
Endpoint:
2002–2004
incident
CRA <20
yrs old
2818,
441
No CRC,
IBD
history
Both, All
underwent
colonoscopy,
no age
exclusion
Self-
administered
FFQ with 55
food and
beverage items
Grain legumes
(beans, lentils, split
peas)
≥3×/wk vs. <1×/mo
OR = 0.67 (0.44–
1.01)
Trend: P = 0.02
Adjusted for age, sex,
education, BMI, and
red meat intake
Prevalent colorectal adenoma
Platz et al., 1997
[74]
U.S., Health and
Professionals’
Follow-up Study
(HPFS)
1986–1994 16,448,
690
No CRA,
IBD
history
Men
40–75 years
All
underwent
colonoscopy
Self-
administered
FFQ with 127
food items for
previous yr
Legume fiber
(beans, lentils,
peas, lima beans,
tofu, soybeans)
Median 2.6 vs. 0.5
g/d
Adjusted for age,
family CRC history,
prior endoscopy,
BMI, smoking,
multivitamin use,
physical activity,
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Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
RR = 0.82 (0.60–
1.11) Trend: P =
0.06
regular aspirin use,
and intake of energy,
alcohol, red meat,
folate, and
methionine
Michels et al.,
2006 [73]
U.S., Nurses’
Health Study
(NHS)
Diet: 1980–
1994
Endpoint:
1980–1998
34,467,
1720
No CRC
and IBD
history
Women
30–55 years in
1976
Self-
administered
FFQ with 61
food items for
previous yr
Legumes (beans,
lentils, peas, lima
beans, tofu,
soybeans)
≥5 vs. ≤1
serving/wk
OR = 0.89 (0.75–
1.05)
Trend: OR = 0.96
(0.93–1.00)
Adjusted for age,
family CRC history,
height, BMI, regular
vigorous exercise,
regular aspirin use,
pack-years of
smoking, current
multivitamin
supplement use,
alcohol consumption,
menopausal status,
postmenopausal
hormone use, and
intake of total energy,
red meat, and
calcium
Colon cancer
Steinmetz et al.,
1994 [70]
U.S., Iowa
Women’s Health
Study (IWHS)
1986–1990 41,837,
212
Women, 55–
69 years at
baseline, no
CRC history
Self-
administered
FFQ with 127
food items for
previous yr
Legumes (beans,
lentils, peas, lima
beans, tofu,
soybeans)
≥1.0 vs. 0
servings/wk
RR = 0.95 (0.66–
1.36)
Adjust for age and
total energy intake
Singh and Fraser,
1998 [69] U.S.,
Adventist Health
Study (AHS)
1976–1982 32,051
157
Non-
hispanic
white
Both
>25 years
Self-
administered
FFQ with 55
food items
Grain legumes
(beans, lentils, split
peas)
>2× vs. <1×/wk
RR = 0.53 (0.33–
0.86)
Adjusted for age, sex,
BMI, physical
activity, parental
CRC history,
smoking, alcohol
consumption, and
aspirin use
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Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
Colorectal cancer
Michels et al.,
2000 [65]
U.S., Nurses’
Health
Study (NHS)
1980–1996 88,764,
724
Women
30–55 years
Self-
administered
FFQ with 127
food items for
previous yr
Legumes (beans,
lentils, peas, lima
beans, tofu,
soybeans)
≥4 vs. <1
serving/wk
RR = 1.26 95% CI
N/A
RR = 1.49 (1.04–
2.12) per additional
serving/wk
Adjusted for age,
family CRC history,
sigmoidoscopy,
height, BMI, pack-
years of smoking,
alcohol consumption,
physical activity,
intake of total energy
and red meat, and
use of menopausal
hormones, aspirin,
and vitamin
supplements
Michels et al.,
2000 [65]
U.S., Health and
Professionals’
Follow-up Study
(HPFS)
1986–1996 47,325,
457
Men
40–75 years
Self-
administered
FFQ with 127
food items for
previous yr
Legumes (beans,
lentils, peas, lima
beans, tofu,
soybeans)
≥4 vs. <1
serving/wk
RR = 0.97 95% CI
N/A
RR = 0.90 (0.57–
1.42) per additional
serving/wk
Adjusted for age,
family CRC history,
sigmoidoscopy,
height, BMI, pack-
years of smoking,
alcohol consumption,
physical activity,
intake of total energy
and red meat, and
use of menopausal
hormones, aspirin,
and vitamin
supplements
Voorrips et al.,
2000 [71]
Netherlands
Cohort Study on
Diet and Cancer
(NCSDC)
1986–1992 Male:
58,279,
514
Women:
62,573,
396
Both,
55–69 years
Self-
administered
FFQ with 155
food items for
previous yr
Grain legumes
(green and lima
beans)
Male: Median 62
vs. 11 g/d
Colon RR = 1.13
(0.77, 1.64)
Rectum: RR = 0.92
(0.58–1.47)
Female: Median 58
vs. 11 g/d
Adjusted for age,
alcohol consumption,
and family CRC
history
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Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
Colon RR = 0.79
(0.52, 1.20)
Rectum: RR = 1.01
(0.53–1.94)
Mai et al., 2003
[64] U.S., Breast
Cancer Detection
Demonstration
Project (BCDDP)
1987–1998 45,491,
487
Women
Age range
N/A
Self-
administered
FFQ with 62
food items for
previous yr
Grain legume fiber
>1.38 vs. <0.20 g/
1000 kcal/d
RR = 0.84 (0.63–
1.10)
Unadjusted
Bingham et al.,
2003 [61]
10 EU countries,
EPIC
1992–2002 519,978,
1065
Both, 35–70
years
Country-
specific FFQ
with 300–350
food items
Legume fiber
Mean: 1.73 vs. 0.45
g/d
HR = 1.04 (0.84–
1.30)
Adjusted for age,
weight, height, sex,
intake of nonfat and
fat energy, and
stratified by center
Bingham et al.,
2005 [62]
10 EU countries,
EPIC
1992–2004 519,978,
1721
Both, 35–70
years
Country-
specific FFQ
with 300–350
food items
Legume fiber
Mean: 1.9/1.0 vs. 0
g/d
HR = 0.94 (0.79–
1.14)
Adjusted for age,
weight, height, sex,
intake of nonfat and
fat energy, and
stratified by center
Lin et al., 2005
[63]
U.S., Women’s
Health Study
(WHS)
1993–2003 39,876,
223
Women
≥45 years
Self-
administered
FFQ with 131
food items for
previous yr
Legumes (dry
beans, lentils, peas,
lima and green
beans, tofu,
soybeans)
Median 0.9 vs. 0.1
serving/d
RR = 0.83 (0.54–
1.28)
Legume fiber
Median 1.8 vs. 0.4
g/d
RR = 0.60 (0.40–
0.91)
Adjusted for age,
randomized
treatment
assignment, BMI,
first-degree CRC
family history, colon
polyp history,
physical activity,
smoking status,
baseline use of
aspirin, hormone
replacements,
menopausal status,
alcohol consumption,
and intake of total
energy and red meat
Nomura et al.,
2007 [66]
U.S., Multiethnic
1993–2001 191,011,
2110
Both,
45–75 years
Self-
administered
Legume fiber Adjusted by age,
ethnicity, time since
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Reference,
cohort, country
Follow-up
period
Study
size, case
no.
Sex, age Diet
assessment
Grain legume,
quantity for
comparison, risk
estimates (95% CI)
Adjustment for
confounders
Cohort Study
(MEC)
FFQ with 180
food items
Men: Median 7.6
vs. 0.3 g/1000
kcal/d
CRC: RR = 0.81
(0.65–1.01)
Ptrend = 0.04
Women: Median
5.8 vs. 0.2 g/1000
kcal/d
CRC: RR = 1.02
(0.82–1.27)
cohort entry, and age
at cohort
Park et al., 2007
[67]
U.S., NIH–AARP
Diet and Health
Study
1995–2000 488,043,
2972
Both,
50–71 years at
baseline
Self-
administered
FFQ with 124
food items for
previous yr
Grain legumes
(dried beans, green
beans, and peas)
Men: Median 0.69
vs. 0.08 servings/d
RR = 0.95 (0.83–
1.09)
Significant for age
adjusted RR = 0.85
(0.74–0.97) Women:
Median 0.81 vs.
0.09 servings/d
RR = 1.13
(0.91–1.40)
Adjusted for
education, physical
activity, smoking,
alcohol consumption,
and intake of total
energy, red meat, and
calcium
Schatzkin et al.,
2007 [68]
U.S., NIH–AARP
Diet and Health
Study
1995–2000 489,611,
2974
Both,
50–71 years at
baseline
Self-
administered
FFQ with 124
food items for
previous yr
Grain legume fiber
Median 2.3 vs. 0.2
g/1000 kcal/d
RR = 0.93 (0.83–
1.04) Significant
for age-and sex-
adjusted RR = 0.89
(0.79–0.99)
Adjusted for sex,
physical activity,
smoking,
menopausal
hormone therapy,
and intake of total
energy, red meat,
calcium, and folate
*Statistically significant association of legume consumption and colorectal neoplasia.
CRC: colorectal cancer; CRA: colorectal adenoma; FFF: food frequency questionnaire; HR: hazard ratio; IBD:
inflammatory bowel disease; N/A: not available; OR: odds ratio; RR: relative risk; 95% CI: 95% confidence interval.
1 serving of legume equals 0.5 cup of cooked legumes (~90 g) [7].
Table 2. Prospective cohort studies of grain legume consumption and colorectal neoplasia.
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For the meta-analysis, we had to exclude the CRC risk estimates of two cohorts because the
risk estimates did not include 95% CI [65], leaving us with 1,533,527 participants including
12,408 cases. When comparing the highest versus the lowest legume intake group, we ob-
served, as shown in Figure 2, a protective effect of grain legume consumption on colorectal
neoplasia (RR = 0.89; 95% CI: 0.59–0.88; P = 0.001). The protective effect attenuated from incident
CRA (RR = 0.72; 95% CI: 0.60–0.87; P <0.001) over prevalent CRA (RR = 0.87; 95% CI: 0.75–1.01;
P = 0.07) to CRC (RR = 0.93; 95% CI: 0.86–1.01; P = 0.08). There was little heterogeneity (18.3%)
among studies, which was further decreased after stratifying for neoplastic endpoint (Figure
2). No significant publication bias was observed (P = 0.13). We observed a nonlinear relation-
ship between legume consumption and colorectal neoplasia, as the protective effect of legume
consumption for incident CRA (Table 2) was limited to the highest legume intake group, which
corresponds to daily consumption of at least 0.5 servings of legumes (~45 g/d). In comparison,
the 2015 U.S. dietary guidelines recommend three servings/wk (~39 g/d), which is lower than
six servings/wk of the 2005 guidelines [7, 76].
Figure 2. Forest plot of legume consumption (highest vs. lowest category) and colorectal neoplasia risk in prospective
studies stratified by type of neoplastic lesion. The dot in each study indicates the estimated risk ratio, vertical bars rep-
resent the 95% CI and the size of gray square box reflects the study’s weight in the random effects Meta-analysis stud-
ies. The straight line indicates no association and the dashed line indicates the summary risk estimate across all
studies. The open diamond on the bottom indicates the pooled risk estimate and the right vertices of the diamond
reflect the 95% CI. CC: colon cancer; RC: rectal cancer; CRC: colorectal cancer; CRA: colorectal adenoma; GrLeg: grain
legume; GrLegF: grain legume fiber; Leg: legume; LegF: legume fiber.
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Our risk estimates (Table 3) are similar to those obtained previously from meta-analyses be-
tween legume consumption (including soybeans) and CRA (RR = 0.73; 95% CI: 0.61–0.88)
and CRC (RR = 0.91; 95% CI: 0.84–0.98) [14, 15], as well as legume fiber consumption and
CRC (RR = 0.89; 95% CI: 0.78–1.02) [16]. Thus, we conclude that there is limited evidence
suggesting that daily grain legume consumption decreases CRC risk in humans, all of which
are based on observational studies. This is consistent with what has been previously con-
cluded for the evidence on the relation between stomach or prostate cancer risk and legume
consumption [34].
Factor Studies Pooled risk ratio Heterogeneity  Eggers  References
(estimates)  RR (95% CI) P I2 (%) P P
Overall 23 (36) 0.84 (0.78–0.90) 0.005 41.9 <0.001 0.02 [46–52, 55–57, 59, 60, 62–64,
66, 67, 69–75]
Endpoint
Incident
adenoma
3 (3) 0.72 (0.60–
0.87) 
<0.001 0 0.76 0.90 [72, 73, 75]
Prevalent
adenoma
8 (10) 0.91 (0.84–
0.99) 
0.03 0 0.73 0.60 [47–52, 73, 74]
Cancer 14 (23) 0.82 (0.74–
0.91) 
<0.001 54.4 0.001 0.02 [46, 55–57, 59, 60, 62–64, 66,
67, 69–71]
Study type
Retrospective 12 (18) 0.77 (0.66–
0.89) 
<0.001 53.3 0.004 0.11 [46–52, 55–57, 59, 60]
Prospective 11 (18) 0.89 (0.83–
0.96) 
0.001 18.3 0.24 0.13 [62–64, 66, 67, 69–75]
Gender
Men 10 (11) 0.89 (0.81–
0.97) 
0.009 0 0.80 0.40 [46, 47, 49, 59, 60, 66, 67, 71,
72, 74]
Women 11 (13) 0.86 (0.75–
0.98) 
0.03 50.7 0.02 0.14 [46, 47, 49, 59, 60, 64, 66, 67,
70, 71]
Legume type
Legume 13 (17) 0.88 (0.82–
0.94) 
<0.001 4.5 0.40 0.10 [48, 49, 51, 57, 59, 60, 62, 63,
66, 70, 73, 74]
Grain legume 11 (19) 0.80 (0.71–
0.92) 
0.001 58.1 0.001 0.09 [46, 47, 50, 52, 55, 56, 64, 67,
69, 71, 72, 75]
Legume part
Grain 18 (29) 0.82 (0.74–
0.89) 
<0.001 49.6 0.001 0.01 [46, 48–52, 55–57, 59, 60, 63,
67, 69–73, 75]
Fiber 6 (8) 0.92 (0.85–
0.99) 
0.02 0 0.78 0.92 [47, 62, 64, 66, 68, 74]
Grain Legume Consumption Inhibits Colorectal Tumorigenesis: A Meta-Analysis of Human and Animal Studies
http://dx.doi.org/10.5772/63099
155
Factor Studies Pooled risk ratio Heterogeneity  Eggers  References
(estimates)  RR (95% CI) P I2 (%) P P
Cancer site
Colon 8 (10) 0.69 (0.54–
0.88) 
0.003 63.6 0.003 0.94 [45, 55–57, 60, 69–71]
Rectum 3 (4) 0.70 (0.49–
1.00) 
0.05 63.9 0.04 0.69 [45, 55, 71]
Continent/country
Europe 4 (8) 0.83 (0.67–
1.03) 
0.09 64.9 0.006 0.77 [55, 57, 62, 71]
USA 16 (23) 0.88 (0.82–
0.94) 
<0.001  24.5 0.14 0.04 [47–52, 59, 63, 64, 66, 67, 69,
70, 72–75]
Pooled risk estimates with 95% confidence intervals in parentheses compare risk of developing colorectal cancer/
adenoma of the highest versus the lowest grain legumes intake group. Study number will not add up to overall
number because for overall study we used most combined risk estimates available. Eggers P-value indicates
probability for publication bias.
Table 3. Higher grain legume consumption decreases risk of colorectal tumorigenesis: meta-analysis of 23 human
studies.
The next step needs to be a long-term intervention study of daily grain legume consumption
in a high CRC risk cohort. Dietary compliance will be a major challenge in Western countries
because <10% of the population consumes grain legumes on a daily basis [6, 10, 11]. Moreover,
it is much easier to take a daily supplement or a medication than consuming a chemo-
preventive diet. At the same time, it is unrealistic to expect a chemo-preventive effect of a food,
supplement, or medication when it is sporadically consumed. We previously identified
markers of dietary compliance for grain legume consumption in human and animal studies
[77], which allows for compliance monitoring. Intention-to-treat analysis, the gold standard
for statistical evaluation of intervention studies, assumes high compliance. Statistical methods
that account for dietary exposure markers and low compliance are needed when evaluating
the evidence from dietary intervention studies.
4. Grain legumes and colorectal neoplasia in animal studies
As shown in Table 4, 14 animal studies evaluated the effect of grain legume consumption on
colorectal tumorigenesis using 253 animals (248 males and five females) on control diets and
355 animals (350 males and five females) on 19 different grain-legume-containing diets [78–
89]. Eight diets contained whole dry beans, seven contained dry bean fractions (three fiber
factions, three ethanol extract, and one ethanol extract residue); two diets each contained lentils
or chickpeas, and one diet each contained black-eyed peas or dry peas. In three studies, the
animals were intragastrically tubed with dry beans and/or dry bean fiber [85, 87], whereas in
the remaining 11 studies grain legumes or their fractions were included in the diet. Ten studies
were conducted with rats and four with mice. All but one study [79] used azoxymethane
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(AOM), which is commonly used in animal models of human CRC to induce DNA mutations
by alkylating DNA primarily at the O6-guanidine residues [90, 91]. After AOM induction, we
promoted tumor formation in two unpublished studies with the colon irritant dextran sodium
sulfate (DSS); this is an established inflammation-associated animal model of human CRC [92].
Bean treatment started before tumor induction in nine studies, after tumor induction in three,
and after tumor induction and promotion in two studies. Study endpoints were ACF in seven
studies, adenomas and adenocarcinomas in five, and tumors in two studies.
Reference Animal Diet, animals/diet Experimental design Tumor endpoints
Colorectal tumors:
Hughes et al.,
1997 [78]
F344 male
rats
Control: casein diet, n =
20
Treatment:
Pinto beans (59% of diet)
n = 21
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 6 wk of age
Diet Start: 1 wk
after last AOM
Study End: 34 wk
after last AOM
Colon adenomas,
adenocarcinomas
(incidence and
multiplicity)
McIntosh et al.,
1998 [79]
Sprague-
Dawley
male rats
Control: modified
AIN-1976, n = 18
Treatment:
Chickpeas (45% of diet)
n = 18
3× DMH (15 mg/kg BW) a wk
apart
First DMH: 9 wk of age
Diet start: 4 wk before
first DMH Study End: 22 wk
after last DMH
Colon adenomas +
adenocarcinomas
(incidence and
multiplicity)
Hangen &
Bennink, 2002
[80]
F344 male
rats
Control: modified
AIN-93G, n = 28
Treatments:
Black beans (75% of diet)
n = 32
Navy beans (75% of diet)
n = 28
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 7 wk of age
Diet Start: 4 wk before
first AOM Study End: 31 wk
after last AOM
Colon adenomas,
adenocarcinomas
(incidence and
multiplicity)
Bobe et al., 2008
[81]
Ob/Ob
male mice
Control: modified
AIN-93G, n = 40
Treatments:
Navy beans (74% of diet)
n = 34
Navy bean ethanol
residue (74% of diet) n =
38
Navy bean ethanol
extract (9% of diet) n=39
2× AOM (7 mg/kg BW) a wk
apart
First AOM: 7 wk of age
Diet Start: 1 wk
after last AOM Study End:
27 wk after last AOM
Colon adenomas,
adenocarcinomas,
tumors (incidence and
multiplicity)
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Reference Animal Diet, animals/diet Experimental design Tumor endpoints
Rondini &
Bennink, 2012
[82]
F344 male
rats
Control: modified
AIN-93G, n = 25
Treatment:
Black beans (74% of diet)
n = 25
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 4 wk of age
Diet Start: 1 wk
after last AOM
Study End: 31 wk
after last AOM
Colon adenomas +
adenocarcinomas
incidence
Bobe et al.
(unpublished)
FVB/N
male mice
Control: AIN-93G, n = 32
Treatment:
Navy bean ethanol
extract (10% of diet) n =
33
AOM (10 mg/kg BW)
6 wk of age
DSS (2% drinking water) 1
week starting 1 wk after
DSS Diet Start: 10 days after
AOM
Study End: 102 days after
AOM
Colorectal tumor
multiplicity
Bobe et al.
(unpublished)
FVB/N
male mice
Control: AIN-93G, n = 20
Treatment:
Navy bean ethanol
extract (10% of diet) n =
20
AOM (10 mg/kg BW)
6 wk of age
DSS (2% drinking water) 1
week starting 1 wk after
DSS Diet Start: 10 days after
AOM
Study End: 53 days after AOM
Colorectal tumor
multiplicity
Colon aberrant crypt foci (ACF):
Rijken et al., 1999
[83]
Sprague-
Dawley
male rats
Control: AIN-93M, n = 15
Treatment:
Dry peas (5.9% of diet) n
= 15
2× AOM
(15 mg/kg BW) 3 d apart
First AOM: 10 wk of age
Diet Start: 2 wk before
first AOM Study End: 11 wk
after last AOM
Colon aberrant crypt foci
(total, multiplicity)
Murillo et al.,
2004 [84]
CF-1
female
mice
Control: Harland Teklad
4% Diet 7001, n = 5
Treatment:
Chickpea flour
(10% of diet) n = 5
2× AOM (10 mg/kg BW) a wk
apart
First AOM: 5 wk of age
Diet Start: 2 wk before
first AOM Study End: 7 wk
after last AOM
Control: 1.13 ACF/cm2
colon 0 >4 foci ACF
Chickpea: 0.41 ACF/cm2
colon 2.2 ± 0.37 >4 foci
ACF
Boateng et al.,
2007 [89]
F344 male
rats
Control: AIN-93G, n = 8
Treatments:
Pinto beans (20% of diet)
n = 8
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 7 wk of age
Diet Start: 3 wk before
Control: 183 ± 23 ACF
Pinto: 64 ± 8 ACF
Peas: 40 ± 4 ACF
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Reference Animal Diet, animals/diet Experimental design Tumor endpoints
Black-eyed peas (20% of
diet) n = 8
first AOM Study End: 9 wk
after last AOM
Feregrino-Perez
et al., 2008 [85]
Sprague-
Dawley
male rats
Control:2018S Harland
Teklad n = 10
Treatments: Daily
intragastric tubing
Dry bean Negro 8025 (3.2
g/kg BW) n = 10
Dry bean Negro 8025
fiber fraction (1.84 g/kg
BW) n = 10
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 5 wk of age
Diet Start: 1 wk before
first AOM Study End: 5 wk
after last AOM
Distal colon zone:
Control: 4.2 ± 0.6 ACF
Dry bean: 2.2 ± 0.6 ACF
Fiber fraction: 2.0 ± 0.8
ACF
Using DAPI stain
Faris et al., 2009
[86]
F344 male
rats
Control: AIN-93G, n = 10
Treatments:
Whole lentils (5% of diet)
n = 10
Split lentils (5% of diet) n
= 9
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 10 wk of age
Diet Start: 5 wk before
first AOM Study End: 17 wk
after last AOM
Control: 178 ± 24 ACF
12.0 ± 1.04 >3 foci ACF
Dry bean: 70 ± 8 ACF
2.66 ± 0.09 >3 foci ACF
Fiber fraction: 94 ± 17
ACF
5.56 ± 1.05 >3 foci ACF
Vergara-
Castaneda et al.,
2010 [87]
Sprague-
Dawley
rats male
Control:2018S Harland
Teklad n = 12
Treatments: Daily
intragastric tubing Dry
bean
Bayo Madero (5.7 g/kg
BW) n = 12
Dry bean Bayo Madero
fiber fraction (2.5 g/kg
BW) n = 10
2× AOM (15 mg/kg BW) a wk
apart
First AOM:
6 wk of age
Diet Start: 1 wk before
first AOM Study End: 7 wk
after last AOM  
Distal colon zone:
Control: 6.6 ± 0.40 ACF
Dry bean: 0.8 ± 0.20ACF
Fiber fraction: 1.5 ± 0.72
ACF
Feregrino-Perez
et al., 2014 [88]
Sprague-
Dawley
male rats
Control:2018S Harland
Teklad n = 10
Treatments: Daily
intragastric tubing
Dry bean Negro 8025
fiber fraction (1.84 g/kg
BW) n = 10
2× AOM (15 mg/kg BW) a wk
apart
First AOM: 5 wk of age
Diet Start: 1 wk before
first AOM Study End: 5 wk
after last AOM
Distal colon zone:
Control: 21.0 ± 3.25 ACF
Fiber fraction: 7.20 ± 2.95
ACF
AOM: azoxymethane; BW: body weight; DMH: dimethylhydrazine; DSS: dextran sodium sulfate. ACF were measured
using methylene blue staining unless otherwise noted.
Table 4. Experimental design and endpoints in animal studies of grain legume intake and colorectal tumorigenesis.
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Table 5 shows individual and pooled risk estimates of the seven studies with tumor endpoints.
For calculating risk estimates of tumor and ACF multiplicity, we calculated standardized mean
differences and variation from reported means and standard errors. Grain legume consump-
tion inhibited colorectal tumorigenesis. The protective effect of dry bean consumption
attenuated with progressive tumor stage from tumor incidence (OR = 0.21; 95% CI: 0.11–0.43)
over combined adenoma and adenocarcinoma incidence (OR = 0.32; 95% CI: 0.17–0.60) to
adenocarcinoma incidence (OR = 0.38; 95% CI: 0.20–0.74). Similarly, the protective effect of
grain legume consumption attenuated from ACF multiplicity (OR = 0.07; 95% CI: 0.03–0.14
with stronger effect on larger ACFs; Table 4) over tumor multiplicity (OR = 0.24; 95% CI: 0.16–
0.36) to combined adenoma and adenocarcinoma multiplicity (OR = 0.52; 95% CI: 0.31–0.89)
and adenocarcinoma multiplicity (OR = 0.52; 95% CI: 0.27–0.98; P = 0.04). Given that the chemo-
preventive effect of legumes was reported when grain legumes were fed before as well as after
tumor induction and/or tumor promotion, we conclude that grain legumes inhibit colorectal
tumorigenesis at different tumor stages.
Reference, Legume Adenocarcinoma Adenoma + adenocarcinoma Tumor
Year Incidence Multiplicity Incidence Multiplicity Incidence Multiplicity
Hughes1997 PintoBW 0.38
(0.10–1.45)
0.19
(0.06–0.60)
0.31
(0.08–1.19)
0.20
(0.06–0.66)
Hangen2002 BlackBW 0.19
(0.05–0.77)
0.25
(0.09–0.75)
Bennink2012 BlackBW 0.15
(0.04–0.52)
Hangen2002 NavyBW 0.30
(0.08–1.11)
0.22
(0.07–0.68)
Bobe2008 NavyBW 1.55
(0.38–6.31)
1.11
(0.48–2.55)
0.59
(0.18–1.98)
0.90
(0.39–2.07)
0.32
(0.11–0.95)
0.29
(0.12–0.68)
Bobe2008 NavyBER 0.24
(0.03–2.28)
0.56
(0.25–1.26)
0.23
(0.07–0.71)
0.61
(0.27–1.36)
0.23
(0.07–0.71)
0.22
(0.09–0.51)
Bobe2008 NavyBEE 0.23
(0.02–2.16)
0.45
(0.20–1.01)
0.09
(0.01–0.74)
0.46
(0.21–1.04)
0.08
(0.02–0.38)
0.17
(0.07–0.39)
BobeUnpubl NavyBEE 0.20
(0.05–0.74)
BobeUnpubl NavyBEE 0.34
(0.14–0.85)
McIntosh1998 ChickpeaW 2.50
(0.65–9.65)
Pooled odds ratio 0.38
(0.20–0.74)
0.52
(0.27–0.98)
0.32
(0.17–0.60)
0.52
(0.31–0.89)
0.21
(0.11–0.43)
0.24
(0.16–0.36)
For multiplicity, odds ratios and their 95% confidence intervals were estimated from reported means and standard
errors by calculating standardized mean differences. B: bean; BEE: bean ethanol extract; BER: bean ethanol residue; W:
whole beans; multiplicity: number of tumor/animal.
The P-values are in this order from left to right: P=0.004; P = 0.04; P< 0.001; P = 0.02; P< 0.001; P< 0.001
Table 5. Risk estimates with 95% confidence intervals (in parentheses) for colorectal tumors in animal studies.
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The animal studies have limitations: first, in four of the seven tumor endpoint studies, grain
legumes made up the majority of the diet (45–75%; Table 4) [78–80, 82], concentrations that are
not relevant for human consumption. However, three studies showed a protective effect of the
ethanol extract of navy beans fed at 10% of the diet (Table 4); the 2015 U.S. dietary guidelines
for legume consumption are equivalent to ~2–5% of the diet [76], concentrations that should
be evaluated in future animal studies. Second, none of the reported studies included more than
one grain legume dosage (Table 4), demonstrating a need for dose-response studies in animal
CRC models. Third, only one study examined the chemo-preventive effect of grain legumes
other than dry beans at the tumor stage (Table 4), indicating a need to evaluate the chemo-
preventive effect of other grain legumes at the tumor stage. Fourth, further research is needed
to demonstrate a chemo-preventive response in female animals, as all but one study [84]
examined the response in male animals. Despite these limitations, there is sufficient evidence
to conclude that at least dry bean consumption probably decreases colorectal tumorigenesis
in male animal models of human CRC.
5. Chemo-preventive compounds in grain legumes
To elucidate which fractions of grain legumes have chemo-preventive properties against
colorectal tumorigenesis, we previously fractionated cooked navy beans using 60% ethanol
[81]. Both the ethanol extract and the residue inhibited colorectal tumorigenesis in AOM-
induced mice, indicating that both fractions contain chemo-preventive compounds. Several
studies conducted by Loarca-Piňa’s research group demonstrated that the non-digestible
fraction of dry beans inhibits colon ACF formation in AOM-induced rats [85, 87].
Grain legumes contain three major carbohydrate classes that inhibited colorectal ACF and
tumor formation in animal CRC models: resistant starches (cooked grain legumes contain 0.6–
4.2%), soluble fiber including the flatulence-inducing α-galacto-oligosaccharides stachyose,
verbascose, and raffinose (cooked grain legumes contain 0–3%), and insoluble fiber (cooked
grain legumes contain 15–23%); concentrations of those carbohydrate classes vary considera-
bly based on processing methods [1, 2, 7, 93–97]. Resistant starches can be effective at 5–10%
of the diet [7, 98–102]. Soluble fiber can inhibit ACF and tumor formation at 2.5–15% of the
diet [103, 104], and insoluble fiber can be effective at 5–15% of the diet [104–107].
Grain legumes contain lipid classes that inhibited colorectal ACF and tumor formation in
animal models of CRC. Plant sterols (e.g., β-sitosterol, campesterol, and stigmasterol; 0.13–
0.24% of grain legume dry weight) attenuate colorectal tumorigenesis in animal studies (gastric
intubation of 10–20 mg β-sitosterol/kg body weight or 0.2% of diet) [108–111]. Saponins (0.1–
0.5% of grain legume dry weight) are glycolipids, which inhibit ACF formation at concentra-
tions of 0.01–3% of the diets [112–116]; the lower concentrations are relevant for human diets
[117]. Processing can decrease saponin concentrations in grain legumes up to 40% [118].
Besides containing phytosterols and saponins, grain legumes are low in lipids and have a
favorable fatty acid composition for chemo-prevention (i.e., low in saturated fatty acids and a
low Ω3: Ω6 fatty acid ratio) [3, 119, 120].
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Grain legumes contain protein classes that inhibited colorectal ACF and tumor formation in
animal models of CRC. Trypsin and chymotrypsin protease inhibitors of the Bowman-Birk
family inhibit at dietary concentrations of 0.1–0.5% of the diet or 20 mg/kg of body weight for
colorectal ACF and tumor formation [121–125]. Lectins (i.e., agglutinins; 0.1–3.5% of grain
legume dry weight), which are glycoproteins that bind to epithelial cells, have been shown to
inhibit cancer growth in animal tumor transplant studies and colon cancer cells [126–128].
Grain legumes have significant α-amylase inhibitor activity, which may indirectly decrease
CRC risk by increasing microbial butyrate production and decreasing blood glucose and
insulin after starch consumption [129]. The importance of Bowman-Birk inhibitors, α-amylase
inhibitors, and lectins is debatable because 80–90% is lost and denatured during soaking and
cooking, respectively [7, 96, 117].
The mineral and vitamin content of grain legumes may confer chemo-preventive effects against
colorectal tumorigenesis. Grain legumes contain high concentrations of folate (83–174 μg/100
g of cooked legumes) and potassium (0.29–0.51% of cooked legumes) and low concentrations
of sodium (<0.01% of cooked legumes) [7]. A high ratio of potassium to sodium has been
reported to decrease CRC risk, and folate intake is established as a protective nutrient against
CRC [130, 131]. Chemo-preventive compounds associated with minerals are phytates (0.1–
1.9% of grain legume dry weight), the primary plant storage forms of phosphorus [117].
Processing decreases phytate content up to 50% [97, 132]. Phytates inhibit ACF formation at
dietary concentrations of 0.02–2% [133–136]; the lower concentrations are relevant for human
diets [137].
Grain legumes are a good dietary source of phenolic compounds (1–10 mg gallic acid equiv-
alents/g legume, which is ~0.1–1.0% of grain legume dry weight) [117, 118, 132, 138, 139], many
of which inhibited colorectal ACF and tumor formation in animal models of CRC. The three
major phenolic groups with chemo-preventive properties are flavonoids (0–5 mg catechin
equivalents/g legume), proanthocyanidins (i.e., condensed tannins; 0.2–12 mg catechin
equivalents/g legume), and phenolic acids (0.02–0.1% of cooked legume dry weight) [118, 132,
138, 139]. Flavonols (i.e., kaempferol and quercetin), anthocyanidins, and flavan-3-ols are major
flavonoid classes in grain legumes that have been demonstrated by us and others to inhibit
colorectal tumor multiplicity at concentrations of 0.05–0.3% of the diet [140–144]. Proantho-
cyanidins can inhibit ACF formation at concentrations of 0.002–1% of the diet or by gavage
[145–147]. Phenolic acids include ferulic acid (~0.003% of grain legume dry weight) that
inhibited ACF formation at concentrations of 0.25–1% [148–150] and sinapic acid that inhibited
ACF formation at concentrations of 20–80 mg/kg of body weight by gavage [151]. The con-
centrations of the phyto-estrogen group’s isoflavonoids (0.005–0.095 mg/kg grain legume) and
lignans (0.018–0.266 mg/kg grain legume) are relatively low in grain legumes [152] and, thus,
probably contribute little to the chemo-preventive effect of grain legumes. Processing and
cooking of grain legumes result in various losses of phenolic compounds, which decreased not
only their antioxidant activities but also their antiproliferative properties against colon cancer
cells [118, 132, 139]. Thus, food processing plays an important role for the chemo-preventive
role of grain legumes [117, 127].
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There is sufficient evidence that grain legumes contain various compounds that can exert
chemo-preventive effects against colorectal tumorigenesis in animal models of CRC at
concentrations that are relevant for human diets. One has to consider that several of the
aforementioned compounds are developed by plants as defense mechanisms against herbi-
vores and are at sufficiently high concentrations to be toxic. It has to be noted that most of the
aforementioned compounds do not show a consistent chemo-preventive effect in animal
models of CRC; further investigation is necessary to elucidate factors, including food proc-
essing, that affect the response. Further studies are also warranted to examine whether the
effect of the chemo-preventive compounds differs when they are consumed alone or in
combination.
6. Molecular mechanisms by which grain legumes inhibit colorectal
tumorigenesis
Given the complex mixture of chemo-preventive compounds in grain legumes, it comes to no
surprise that grain legumes inhibit hallmarks of cancer [153, 154] at multiple stages of the
colorectal tumorigenesis process. (A) Grain legumes can inhibit tumor induction (i.e., the
transition from normal to initiated colorectal epithelial cells). First, grain legumes can alter the
metabolism of carcinogens (i.e., increased degradation) and pre-carcinogens (i.e., decreased
activation). This is accomplished directly by activating the expression of cytochrome P450 and
UDP-glucuronosyltransferase (UGT) protein-encoding genes in the liver and indirectly by
altering microbiome metabolism of carcinogens (e.g., decreased β-glucuronidase activity) in
the colon [87, 155]. Second, grain legumes can act as antioxidants and induce genes involved
in the detection and repair of mutated genes [156, 157]. Third, grain legumes may prevent the
exposure of colorectal epithelial cells to carcinogens in food and bile by (a) binding carcinogens
with non-digestible grain legume compounds [87, 158] and by (b) increasing mucin production
of colorectal epithelial cells [159]. Fourth, grain legumes can decrease the colon pH [80] and
promote the growth of probiotic bacteria [160] and thereby inhibit the growth of genotoxic
bacteria [161, 162].
(B) Grain legumes can inhibit tumor promotion and progression (i.e., the transformation from
initiated to neoplastic colorectal epithelial cells). First, grain legumes can increase apoptosis
through the mitochondrial-mediated and death receptor-mediated pathways in neoplastic
colorectal epithelial cells [88, 156] and colon cancer cell lines [163–165]. Second, grain legumes
can inhibit survival of neoplastic colorectal epithelial cells by attenuating the NF-kB pathway
[163–165]. Third, grain legumes can decrease proliferation of neoplastic colorectal epithelial
cells [156, 163] by inducing genes that promote cell cycle arrest in G1/S and G2/M phases
through p53-mediated pathways [82, 156, 165]. Fourth, grain legumes can inhibit survival and
proliferation of neoplastic cells by suppressing the Akt (protein kinase B)/mTOR (mammalian
target of rapamycin) pathway and upregulating the AMPK pathway, as shown for mammary
carcinomas [166, 167]. In addition, upregulation of the AMPK and p53 pathway and suppres-
sion of the Akt/mTOR pathway may limit the nutrient and energy supply for the rapidly
growing cancer cells and thereby inhibit tumor growth and progression [168–170]. Fifth, grain
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legumes can inhibit survival and proliferation of neoplastic colorectal epithelial cells through
increased butyrate production in the colon [80, 163, 171].
(C) Grain legumes can inhibit tumor promotion and progression indirectly by limiting and/or
resolving inflammation. Inflammation creates a tumor microenvironment that encourages
neoplastic transformations and promotes survival and proliferation of neoplastic colorectal
epithelial cells. We previously showed in the Polyp Prevention Trial that the chemo-preventive
effect of grain legumes against CRA recurrence is linked to a decrease in serum interleukin
(IL)-6 [172]. Moreover, we demonstrated in AOM-induced ob/ob mice that navy beans and
their ethanol extract decreased concomitantly colorectal neoplasia and IL-6 in serum and colon
mucosa [173]. In support, others demonstrated that grain legumes can attenuate the DSS-
induced increase in serum cytokine concentrations [139, 159]. Multiple mechanisms are
involved in the anti-inflammatory effect of grain legumes: first, grain legume fractions can act
as antioxidants and inhibit NF-kB pathways and gene expression of COX-2 and tumor necrosis
factor (TNF)-α [165, 174]; second, grain legume consumption can increase mucin gene
expression in the colon and thereby preserve epithelial integrity during inflammation [82,
159]; third, grain legumes can promote microbial butyrate production in the colon, which has
anti-inflammatory and antitumor effects [175]; fourth, grain legumes can promote the growth
of probiotic bacteria [160] and thereby inhibit the growth of inflammation-inducing bacteria
[162, 176].
There is sufficient evidence in human studies, animal models, and colon cancer cell lines for
multiple molecular pathways/mechanisms by which grain legume consumption inhibits early
stages of colorectal tumorigenesis (i.e., tumor induction, promotion, and progression). The
main molecular mechanisms involved are preventing genotoxic hits, DNA repair, inhibiting
survival and proliferation of neoplastic colorectal epithelial cells, preventing, limiting, and/or
resolving inflammation, and limiting nutrient supply for neoplastic colorectal epithelial cells.
Identification of grain legume response biomarkers (i.e., indicators that are linked to both grain
legume consumption and inhibition of colorectal tumorigenesis such as IL-6) will be important
to evaluate the efficacy of grain legumes in future long-term intervention studies in humans.
Grain legume consumption alters the composition and metabolism of colon microbiota, cell
cycle kinetics, and metabolism of colorectal epithelial cells, as well as host immune response
and barrier function of the colon. Future studies are warranted to examine how grain legumes
and their components alter the interplay between microbiota and host. Furthermore, more
research is needed to understand the effect of grain legumes on the later stages of colorectal
carcinogenesis (i.e., metastasis and invasion).
7. Conclusions
The objective of this chapter was to evaluate the evidence of a chemo-preventive role of grain
legume consumption in colorectal tumorigenesis. Based on a literature review and meta-
analyses, we conclude that there is limited evidence from case-control and cohort studies
suggesting that daily grain legume consumption decreases CRC risk in humans. There is
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considerable preclinical evidence in animal models of CRC that supports a chemo-preventive
effect of dry beans in male animal CRC models. There is sufficient evidence that grain legumes
contain various compounds that can exert chemo-preventive effects against colorectal
tumorigenesis in animal models of CRC. This is accomplished at concentrations that are
relevant for human diets through multiple molecular pathways, which are critical for
induction and clonal expansion of neoplastic colorectal epithelial cells. In summary, on the
basis of the current evidence, daily grain legume consumption confers chemo-preventive
effects against CRC. The next step is to conduct a long-term grain legume CRC prevention
intervention study in humans to further elucidate the effects of daily grain legume consump-
tion using grain legume exposure biomarkers to validate compliance and grain legume
response biomarkers to monitor efficacy.
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